The jab - designed by the Belgian company Janssen - uses a genetically modified common cold virus to train the immune system.
It comes a week after preliminary results showed another vaccine offered 90% protection. BBC News
See also:
- Covid-19: Next two weeks 'crucial' for ending lockdown BBC News
- 'Covid-19: Normal life back next winter, says vaccine creator BBC News
- Coronavirus: Safety officials had 'political' pressure' to approve PPE BBC News
- Covid: Children more likely to be infected in second wave BBC News
- Coronavirus: Patients face long waits for hospital ops in England BBC News
- Covid: Care home visitors to trial regular testing BBC News
- Covid-19: Labour calls for law to stop anti-vaccination fake news online BBC News
- Why does COVID-19 kill some people and spare others? The Daily Mail
- Schools are to blame for more than a thousand outbreaks of coronavirus since September The Daily Mail
- Coronavirus: PPE 'is STILL being denied to some NHS workers' despite huge stockpiles The Daily Mail
- Don’t put key workers at end of the Covid vaccine queue, warn UK unions The Guardian
- Covid vaccines in the UK: who is in charge, and what is the plan? The Guardian
- NHS needs extra £4bn next year because of Covid, Rishi Sunak told The Guardian
- England's test and trace system hit by 'huge' IT problems last month The Guardian
- Better, smarter, local response systems are the only way to avoid further lockdowns The Guardian
- ‘A long and difficult slog’: Chris Whitty predicts hardest winter for NHS in recent memory The Independent
- Specialist ‘long Covid’ clinics to be launched across England The Independent
- Covid UK deaths up by 462 over 24 hours The Independent
- COVID-19: Boris Johnson self-isolating after meeting with MP who tested positive for coronavirus Sky News
No comments:
Post a Comment